A popular weight-loss drug may be changing how doctors treat obesity—but scientists are just starting to uncover exactly how ...

For patients with a body mass index (BMI) of 70 or higher, metabolic surgery is a highly effective treatment for this form of ...

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...

After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk ...

Researchers found GLP-1s may modestly reduce the risk of 14 obesity-related cancers, especially colorectal cancer, when ...

A new study suggests that regularly eating collagen-enriched bars could lead to weight loss. Here's what to know.

The FDA has been cut off from producing compounded weight-loss drugs such as Ozempic, Mounjaro or Wegovy, the most effective ...

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

This study shows that midlife weight loss, without medical interventions, reduces chronic disease risk and supports longevity ...

GLP-1 receptor agonists may modestly reduce the risk for 14 obesity-related cancers, especially colorectal cancer, among ...

Scientists found brain cells behind semaglutide’s weight-loss power—and they don’t cause the nasty side effects.